Filter Results:
(347)
Show Results For
- All HBS Web
(578)
- People (4)
- News (149)
- Research (347)
- Events (2)
- Multimedia (4)
- Faculty Publications (168)
Show Results For
- All HBS Web
(578)
- People (4)
- News (149)
- Research (347)
- Events (2)
- Multimedia (4)
- Faculty Publications (168)
Sort by
- 13 Jul 2020
- Research & Ideas
Merck CEO Ken Frazier Discusses a COVID Cure, Racism, and Why Leaders Need to Walk the Talk
As chairman and CEO of the leading vaccine producer in the world, pharmaceutical giant Merck & Co., Ken Frazier has one of the highest-profile positions in global business. But Frazier, who is leading one of the firms on a charge to View Details
- 08 Feb 2000
- Research & Ideas
Building Effective R&D Capabilities Abroad
"Building Effective R&D Capabilities Abroad," Walter Kuemmerle looks at changes in the research & development function in the global economy. A centralized R&D approach will no longer suffice, says Kuemmerle, for two... View Details
Keywords: by Walter Kuemmerle
- 20 Oct 2011
- Research & Ideas
Getting the Marketing Mix Right
to the effectiveness of their marketing instruments” Thomas J. Steenburgh, an associate professor in the Marketing Unit at Harvard Business School, has developed a new analytical tool that more accurately measures the effectiveness of... View Details
Keywords: by Dina Gerdeman
- 10 Oct 2017
- First Look
First Look at New Research and Ideas, October 10, 2017
fruitful new agendas for research on the political-economic nexus as it has developed in the Western world since the end of the Middle Ages. New Perspectives on the History of Political Economy brings together a select group of young and... View Details
Keywords: Sean Silverthorne
- 15 Nov 2018
- Book
Can the Global Food Industry Overcome Public Distrust?
JamesBrey Food is the largest segment of the global economy. It is also widely recognized as more critical for human health than any pharmaceutical drug on the planet. But significant changes in the industry are making people lose trust in many institutions involved in... View Details
- 03 Mar 2009
- First Look
First Look: March 3, 2009
The use of Tamiflu in such a crisis would allow the world to respond immediately, rather than having to wait for development of a vaccine which had limitations in its effectiveness, and the drug had been... View Details
Keywords: Martha Lagace
- 25 Aug 2003
- Research & Ideas
Why IT Does Matter
dropped. Similar situations have transpired with the advent of digitized photography, use of radio frequencies for various handheld IT appliances, and the development of such products as elevators that call in to the service center or to... View Details
Keywords: by F. Warren McFarlan & Richard L. Nolan
- 11 May 2010
- First Look
First Look: May 11
rapid evolution of the biopharmaceutical industry. In the early 2000s, as Millennium's competitive advantage in early-stage research slipped away and its losses mounted, founder and CEO Mark Levin moved the firm downstream away from research and towards View Details
Keywords: Martha Lagace
- 01 Aug 2017
- First Look
First Look at New Research and Ideas, August 1
structure the background against which business operates. The aim is to develop a plausible framework for managerial decision-making that respects the fact of value pluralism in a global economy and that fosters meaningful criticism of... View Details
Keywords: Sean Silverthorne
- 12 Jan 2016
- First Look
January 12, 2016
November–December 2015 Operations Research Active Postmarketing Drug Surveillance for Multiple Adverse Events By: Goh, Joel, Margrét V. Bjarnadóttir, Mohsen Bayati, and Stefanos A. Zenios Abstract—Postmarketing View Details
Keywords: Carmen Nobel
- 24 May 2011
- First Look
First Look: May 24
and further development of the original cluster framework. The fourth part then explores the policy implications to be drawn from Porter's work on clusters. Porter develops recommendations on how to leverage... View Details
Keywords: Sean Silverthorne
- 07 Aug 2007
- First Look
First Look: August 7, 2007
and issues around current practices. Purchase this note: http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=807124 U.S. Food and Drug Administration Harvard Business School Note 807-050 Describes the U.S. FDA with particular... View Details
Keywords: Martha Lagace
- 30 Oct 2007
- First Look
First Look: October 30, 2007
in the multi-agent settings in which these decisions typically occur. In this paper, we develop a model that extends neural nets techniques to capture recognition processes in groups of decision-makers. We use the model to derive some... View Details
Keywords: Sean Silverthorne
- 29 Jan 2021
- Op-Ed
How Influencers, Celebrities, and FOMO Can Win Over Vaccine Skeptics
vaccination efforts. In contrast to the product-centric view employed to develop and distribute the vaccines, the shots-in-arms problem of convincing people to be vaccinated requires patient- or customer-centric solutions. [div... View Details
- 08 Jun 2010
- First Look
First Look: June 8
decisions to employees further down the managerial hierarchy. Economists have developed a range of theories to account for delegation, but there is less empirical evidence, especially across countries. This has limited the ability to... View Details
Keywords: Martha Lagace
- 19 Sep 2016
- Research & Ideas
Why Isn't Business Research More Relevant to Business Practitioners?
disciplines, where academic research is leading to the development of a second skin that could improve drug delivery or alerting farmers and scientists on how to reduce nitrous oxide emissions from... View Details
- 07 Aug 2000
- Research & Ideas
The Business of Biotech
developments suggest that doctors will eventually be able to treat patients more effectively with medicine tailored to their genetic makeup, including, in some cases, gene replacement therapies. "The View Details
- 23 Aug 2016
- First Look
August 23, 2016
science education from around the world as they discuss regional trends and models, with a specific focus on developments in and cooperation with China. Focusing on why this model responds to the twenty-first century requirements for... View Details
Keywords: Sean Silverthorne
- 13 Jan 2003
- Research & Ideas
Making Biotech Work as a Business
technologies for drug discovery.) And patients with previously unmet medical needs can now get treatments that were not available before. That should be inspiring, he reminded the audience. Economic frustrations remain, however. Pisano... View Details
- 15 Jan 2013
- First Look
First Look: January 15
company was hurt by long delays in bringing Bydureon, a once-a-week version of Byetta, to market, which allowed a competitor time to establish itself in the once-a-week market. Amylin also failed to develop a marketable anti-obesity View Details
Keywords: Sean Silverthorne